Skip to main content
Contact Us
Subscribe
E-Edition
86°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Corbus Pharmaceuticals Holdings, Inc. - Common Stock
(NQ:
CRBP
)
4.915
-0.285 (-5.48%)
Streaming Delayed Price
Updated: 3:54 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Corbus Pharmaceuticals Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Cannabis Stock Movers For April 2, 2025
April 02, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 1, 2025
April 01, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For March 28, 2025
March 28, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For March 24, 2025
March 24, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For March 18, 2025
March 18, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For February 17, 2025
February 17, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate
February 14, 2025
Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.
Via
Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For January 20, 2025
January 20, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For October 23, 2024
October 23, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For October 21, 2024
October 21, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For October 21, 2024
October 21, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From October 9, 2024
October 09, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For October 8, 2024
October 08, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From October 4, 2024
October 04, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
October 04, 2024
Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention.
Via
Investor's Business Daily
Cannabis Stock Movers For October 2, 2024
October 02, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From October 1, 2024
October 01, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For September 25, 2024
September 25, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 25, 2024
Via
Benzinga
Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now
September 23, 2024
Corbus Pharmaceuticals received buy ratings from H.C. Wainwright and Oppenheimer, citing the company's diversified pipeline.
Via
Benzinga
Cannabis Stock Movers For September 20, 2024
September 20, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
September 20, 2024
Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose. However, investors reacted to limited gains at higher doses. Corbus...
Via
Benzinga
Crude Oil Moves Higher; Sable Offshore Shares Slide
September 20, 2024
Via
Benzinga
Exposures
Fossil Fuels
Gold Gains Over 1%; Battalion Oil Shares Spike Higher
September 20, 2024
Via
Benzinga
Corbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial Disappoints
September 20, 2024
Corbus Pharmaceuticals and Novo Nordisk stocks plunge following cannabinoid receptor drug trials, raising concerns over weight loss results.
Via
Benzinga
Novo Dives — And Corbus Crashes — After New Weight-Loss Drug Causes Neuropsychiatric Effects
September 20, 2024
Shares of Corbus, which is working on a similar drug, also crashed on Novo Nordisk's news.
Via
Investor's Business Daily
US Stocks Edge Lower; FedEx Earnings Miss Views
September 20, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
Bullish Sentiment Across The Cannabis Space - Check Full Movers For September 19, 2024
September 19, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Wednesday For Marijuana Stocks - Australis Capital, Leafbuyer Techs Among Top Gainers
September 18, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For September 17, 2024
September 17, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
